Inactive Instrument

Company Teva Pharma Ind. Nyse

Equities

Pharmaceuticals

Business Summary

Teva Pharmaceutical Industries Limited is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sales per Business

ILS in Million2022Weight2023Weight Delta
Generics, Innovative Medicines and Over-the-counter Products
100.0 %
50,147 100.0 % 58,440 100.0 % +16.54%

Sales per region

ILS in Million2022Weight2023Weight Delta
North America
51.3 %
25,038 49.9 % 29,961 51.3 % +19.66%
Europe
30.5 %
15,204 30.3 % 17,839 30.5 % +17.33%
International
12.4 %
6,394 12.8 % 7,221 12.4 % +12.94%
Global
5.8 %
3,511 7.0 % 3,415 5.8 % -2.74%

Shareholders

NameEquities%Valuation
Capital Research & Management Co. (Global Investors)
10.24 %
114,793,989 10.24 % 1 634 M $
KSM Mutual Funds Ltd.
1.121 %
12,569,244 1.121 % 179 M $
Migdal Mutual Funds Ltd.
0.5102 %
5,719,493 0.5102 % 81 M $
2,073,223 0.1849 % 30 M $
1,997,707 0.1782 % 28 M $
Excellence Nessuah Mutual Funds Management Ltd.
0.1622 %
1,817,855 0.1622 % 26 M $
1,574,575 0.1405 % 22 M $
I. G. Investment Management Ltd.
0.0454 %
508,436 0.0454 % 7 M $
IBI Mutual Funds Management (1978) Ltd.
0.0405 %
453,548 0.0405 % 6 M $
Eurizon Capital SGR SpA
0.0393 %
440,794 0.0393 % 6 M $
NameEquities%Valuation
Ion Asset Management Ltd.
3.597 %
40,327,407 3.597 % 569 M $
BlackRock Advisors LLC
3.247 %
36,399,055 3.247 % 514 M $
Lingotto Investment Management LLP
3.074 %
34,457,656 3.074 % 486 M $
34,383,192 3.067 % 485 M $
32,804,131 2.926 % 463 M $
28,919,540 2.580 % 408 M $
28,533,099 2.545 % 403 M $
28,128,744 2.509 % 397 M $
Slate Path Capital LP
2.340 %
26,231,184 2.340 % 370 M $
Rubric Capital Management LP
1.626 %
18,226,601 1.626 % 257 M $

Holdings

NameEquities%Valuation
7,646 25.32% 61,106,834 $

Company contact information

Teva Pharmaceutical Industries Ltd.

124 Dvora HaNevi'a Street

6944020, Tel Aviv

+972 3 914 8213

http://www.tevapharm.com
address Teva Pharma Ind.

Group companies

NameCategory and Sector
Teva Pharmaceutical Finance Co. BV
Finance/Rental/Leasing
Teva Pharmaceutical Finance Netherlands III BV
Finance/Rental/Leasing
Teva Pharmaceutical Finance Netherlands II BV
Finance/Rental/Leasing
Pharmaceuticals: Major
Teva Pharmaceutical Finance IV BV
Finance/Rental/Leasing
Teva Finance Services BV
Teva Finance Services II BV
Financial Conglomerates
Pharmaceuticals: Major